The NXTGEN HIGHTECH program drives the development and standardization of organ-on-a-chip technology. The Dutch consortium brings together more than 330 parties from industry and knowledge institutes to advance a range of next-generation technologies and to establish scalable, viable market pipelines.
The aim of organ-on-a-chip technology is to mimic human physiology, presenting a biologically relevant in vitro testing environment which maintains tissue-specific functions. In this way, it is possible to facilitate early in vitro testing of how a therapeutic might affect human cells with a functional readout.
Welcome to this 33rd edition of ZOOM, a magazine dedicated to preclinical trials and clinical…
Precision and reliability are essential in dermatology and aesthetics. The Antera 3D CS by Miravex…
PhD Trials, one of the leading CROs for performing in vivo studies with cosmetic products…